N-(4-((1S)-1-((R)-(4-Chlorophenyl)(7-fluoro-5-methyl-1H-indol-3-yl)methyl)butyl)benzoyl)-beta-alanine
MK-3577 is under investigation in clinical trial NCT00868790 (A Study of the Safety and Efficacy of MK-3577 in Participants With Type 2 Diabetes Mellitus (MK-3577-009)).